Performance of [F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease

Authors :: Salloway, Stephen
Gamez, Jose E
Singh, Upinder
Sadowsky, Carl H
Villena, Teresa
Sabbagh, Marwan N
Beach, Thomas G
Duara, Ranjan
Fleisher, Adam S
Frey, Kirk A
Walker, Zuzana
Hunjan, Arvinder
Escovar, Yavir M
Agronin, Marc E
Ross, Joel
Bozoki, Andrea
Akinola, Mary
Shi, Jiong
Vandenberghe, Rik
Ikonomovic, Milos D
Sherwin, Paul F
Farrar, Gill
Smith, Adrian PL
Buckley, Christopher J
Thal, Dietmar
Zanette, Michelle
Curtis, Craig
Publication Year :: 2017
Abstract: Performance of the amyloid tracer [F]flutemetamol was evaluated against three pathology standard of truth (SoT) measures including neuritic plaques (CERAD "original" and "modified" and the amyloid component of the 2012 NIA-AA guidelines). ispartof: Alzheimer's & dementia (Amsterdam, Netherlands) vol:9 pages:25-34 ispartof: location:United States status: published

Tools